Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of IVIG in treatment-resistant painful neuropathy
2007-007007-32Phase 2Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of immune globulin in neuropathy and diabetic neuropathy, sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Pain intensity (VAS). Started Jul 2008; status: completed.
02
Drugs
immune globulin
03
Conditions
neuropathydiabetic neuropathy
Beyond the preview
Go deeper on 2007-007007-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007007-32.